Phase III randomised comparison of gemcitabine (GEM) versus gemcitabine plus capecitabine (GEM-CAP) in patients with advanced pancreatic cancer

被引：0
|
作者：
不详
机构：
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [41] A phase I study, with expanded cohort, of biweekly fixed-dose rate gemcitabine (FDR GEM) plus capecitabine (CAP) in patients with advanced pancreatic (APC) and biliary carcinomas (ABC)
    Espinoza, A. M.
    Ko, A. H.
    Venook, A. P.
    Bergsland, E. K.
    Jones, K. A.
    Kelley, R. K.
    Korn, W. M.
    Dito, E.
    Ong, A.
    Tempero, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] Updated results of the GEST study: Randomized phase III study of gemcitabine plus S-1 (GS) versus S-1 versus gemcitabine (GEM) in unresectable advanced pancreatic cancer in Japan and Taiwan
    Fukutomi, Akira
    Okusaka, Takuji
    Sugimori, Kazuya
    Ueno, Hideki
    Ioka, Tatsuya
    Ohkawa, Shinichi
    Boku, Narikazu
    Yamao, Kenji
    Mizumoto, Kazuhiro
    Furuse, Junji
    Funakoshi, Akihiro
    Hatori, Takashi
    Yamaguchi, Taketo
    Egawa, Shinichi
    Sato, Atsushi
    Ohashi, Yasuo
    Cheng, Ann-Lii
    Tanaka, Masao
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] A randomised phase II study of gemcitabine versus mitomycin C versus gemcitabine/mitomycin C in patients with advanced pancreatic cancer
    Tuinmann, G.
    Mueller, L.
    Hossfeld, D.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] APACT: Phase III randomized trial of adjuvant treatment with nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC).
    Tempero, Margaret A.
    Cardin, Dana Backlund
    Goldstein, David
    O'Reilly, Eileen Mary
    Philip, Agop Philip
    Riess, Hanno
    Macarulla, Teresa
    Yung, Lotus
    Li, Mingyu
    Lu, Brian D.
    Biankin, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [45] Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
    Kindler, Hedy L.
    Ioka, Tatsuya
    Richel, Dirk J.
    Bennouna, Jaafar
    Letourneau, Richard
    Okusaka, Takuji
    Funakoshi, Akihiro
    Furuse, Junji
    Park, Young Suk
    Ohkawa, Shinichi
    Springett, Gregory M.
    Wasan, Harpreet S.
    Trask, Peter C.
    Bycott, Paul
    Ricart, Alejandro D.
    Kim, Sinil
    Van Cutsem, Eric
    LANCET ONCOLOGY, 2011, 12 (03): : 256 - 262
  • [46] Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?
    Hao, Fulong
    Chen, Xinyang
    Li, Hancong
    Feng, Qingbo
    Hou, Yong
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (01) : 478 - 479
  • [47] Docetaxel (Do) and gemcitabine (Gem) in advanced pancreatic cancer (APC) patients (pts): A multicentre study
    Des Guetz, G.
    Chauvenet, L.
    Paraiso, D.
    Mayeur, D.
    Aparicio, T.
    Chirat, E.
    Boiron, C.
    Bouleuc-Parrot, C.
    Pujade-Lauraine, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
    Heinemann, Volker
    Quietzsch, Detlef
    Gieseler, Frank
    Gonnermann, Michael
    Schoenekaes, Herbert
    Rost, Andreas
    Neuhaus, Horst
    Haag, Caroline
    Clemens, Michael
    Heinrich, Bernard
    Vehling-Kaiser, Ursula
    Fuchs, Martin
    Fleckenstein, Doris
    Gesierich, Wolfgang
    Uthgenannt, Dirk
    Einsele, Hermann
    Holstege, Axel
    Hinke, Axel
    Schalhorn, Andreas
    Wilkowski, Ralf
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3946 - 3952
  • [49] A randomized phase II study of gemcitabine (GEM) plus S-1 combination chemotherapy versus GEM monotherapy in patients (pts) with advanced biliary tract cancer (BTC)
    Sasaki, T.
    Isayama, H.
    Ito, Y.
    Yasuda, I.
    Toda, N.
    Hanada, K.
    Matsubara, S.
    Maoguchi, H.
    Yashlma, Y.
    Kamada, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [50] Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
    Borad, Mitesh J.
    Reddy, Shantan G.
    Bahary, Nathan
    Uronis, Hope E.
    Sigal, Darren
    Cohn, Allen L.
    Schelman, William R.
    Stephenson, Joe, Jr.
    Chiorean, E. Gabriela
    Rosen, Peter J.
    Ulrich, Brian
    Dragovich, Tomislav
    Del Prete, Salvatore A.
    Rarick, Mark
    Eng, Clarence
    Kroll, Stew
    Ryan, David P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (13) : 1475 - 1481
12345